Clinical trial

Study of 3,5-Diiodothyropropionic Acid (DITPA) in Hypercholesterolemic Patients

NCT00311987 · Johns Hopkins University, Other · Terminated

Key facts

NCT number NCT00311987
Title Study of 3,5-Diiodothyropropionic Acid (DITPA) in Hypercholesterolemic Patients
Official title A Randomized, Double-Blind Placebo-Controlled Study of 3,5-diiodothyropropionic Acid (DITPA) in Combination With Standard Therapy to Attain NCEP ATP III Goal for LDL Cholesterol in Hypercholesterolemic Patients
Lead sponsor Johns Hopkins University, Other
Status Terminated
Phase Phase 1/Phase 2
Study type Interventional
Conditions Hypercholesterolemia
Intervention type Drug
Interventions 3, 5-Diiodothyropropionic acid (DITPA) therapy
Enrollment 60
Start date Apr 1, 2006
Completion Apr 1, 2007
First posted Apr 7, 2006
Last update posted Apr 2, 2013
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • 10–99 Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies